The European Medicines Agency (EMA) Published Safety Monitoring Plan and Guidance on Risk Management Planning for COVID-19 Vaccines
23 novembre 2020
The plan prepared by EMA and the national competent authorities (NCAs) in EU Member States, outlines how relevant new information emerging after the authorisation and uptake of COVID-19 vaccines in the pandemic situation will be collected and promptly reviewed.
For further information, see here.